Effect of royal Jelly and Omega-3 in multiple sclerosis

Phase 2

• Conditions: Condition 1: Multiple sclerosis. Condition 2: Neurasthenia.; Multiple sclerosis; Neurasthenia

• Registration Number: IRCT20111105008013N3
• Lead Sponsor: Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Multiple sclerosis patients have fatigue

Exclusion Criteria

other neurological disease
Diseases like diabetes and autoimmune diseases
new attack in the last month
Emergence of drug side effects
New disease attack
Pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue. Timepoint: Start intervention and a month later. Method of measurement: MFIS questionnaire.;Quality of Life. Timepoint: Start intervention and a month later. Method of measurement: MSQL-54 questionnaire.;Blood parameters. Timepoint: MSQL-54 questionnaire. Method of measurement: Blood laboratory analysis.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: One month after the intervention began. Method of measurement: Observation.